Hi Cheri,
Now and then I have read about the possibility of increased risk for AML transformation when patients get granulocyt colony stimulating factors like Neupogen or Neulasta. The risk is probably very low and I have not read anything about a difference between the two drugs.
http://www.ncbi.nlm.nih.gov/pubmed/20673585
Kind regards
Birgitta-A
2 Neupogen injections/week Sept 2007 - June 2010 since then 3 inj/week less than 5 % blast cells